A new look at the pathogenesis of Pompe disease

Clinical Therapeutics

Volumn 30, Issue SUPPL. 3, 2008, Pages

  Raben, Nina ^a   Plotz, Paul H ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ENZYME;

ARTICLE; AUTOPHAGY; CLINICAL FEATURE; DISEASE COURSE; DRUG MEGADOSE; ENZYME REPLACEMENT; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; MORQUIO SYNDROME; MULTIPLE SULFATASE DEFICIENCY; MUSCLE FUNCTION; NEURONAL CEROID LIPOFUSCINOSIS; NIEMANN PICK DISEASE; NONHUMAN; PATHOGENESIS; SANFILIPPO SYNDROME; SKELETAL MUSCLE;

EID: 56049101609     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(08)00364-0     Document Type: Article

References (14)

1. Griffin J.L. Infantile acid maltase deficiency. I. Muscle fiber destruction after lysosomal rupture. Virchows Arch B Cell Pathol Incl Mol Pathol 45 (1984) 23-36
2. Thurberg B.L., Lynch Maloney C., Vaccaro C., et al. Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Invest 86 (2006) 1208-1220
3. Fukuda T., Ewan L., Bauer M., et al. Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease. Ann Neurol 59 (2006) 700-708
4. Fukuda T., Ahearn M., Roberts A., et al. Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease. Mol Ther 14 (2006) 831-839
5. Fukuda T., Roberts A., Ahearn M., et al. Autophagy and lysosomes in Pompe disease. Autophagy 2 (2006) 318-320
6. Raben N., Takikita S., Pittis M.G., et al. Deconstructing Pompe disease by analyzing single muscle fibers: To see a world in a grain of sand. Autophagy 3 (2007) 546-552
7. Raben N., Fukuda T., Gilbert A.L., et al. Replacing acid alpha-glucosidase in Pompe disease: Recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers. Mol Ther 11 (2005) 48-56
8. Kishnani P.S., Nicolino M., Voit T., et al. Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantileonset Pompe disease. J Pediatr 149 (2006) 89-97
9. Kishnani P.S., Corzo D., Nicolino M., et al. Recombinant human acid [alpha]-glucosidase: Major clinical benefits in infantileonset Pompe disease. Neurology 68 (2007) 99-109
10. Kiselyov K., Jennigs Jr. J.J., Rbaibi Y., and Chu C.T. Autophagy, mitochondria and cell death in lysosomal storage diseases. Autophagy 3 (2007) 259-262
11. Jennings Jr. J.J., Zhu J.H., Rbaibi Y., et al. Mitochondrial aberrations in mucolipidosis type IV. J Biol Chem 281 (2006) 39041-39050
12. Settembre C., Fraldi A., Rubinsztein D.C., and Ballabio A. Lysosomal storage diseases as disorders of autophagy. Autophagy 4 (2008) 113-114
13. Settembre C., Fraldi A., Jahreiss L., et al. A block of autophagy in lysosomal storage disorders. Hum Mol Genet 17 (2008) 119-129
14. Koike M., Shibata M., Waguri S., et al. Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). Am J Pathol 167 (2005) 1713-1728